David Price Selected Research

Nebulizers and Vaporizers (Inhaler)

1/2022	Perceptions, attitudes, and behaviors of short-acting beta2 agonist users: an Australian cross-sectional community pharmacy-based study.
1/2022	Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.
12/2021	Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study).
1/2021	Patient perceptions of the re-usable Respimatt® Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD study.
1/2021	Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes.
3/2020	Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety.
1/2020	Treatment Adherence in Adolescents with Asthma.
12/2019	A multinational observational study identifying primary care patients at risk of overestimation of asthma control.
12/2019	An innovative corticosteroid/long-acting β2-agonist breath-triggered inhaler: facilitating lung delivery of fluticasone propionate/formoterol fumarate for the treatment of asthma.
6/2019	Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Price Research Topics

Disease

120	Asthma (Bronchial Asthma) 01/2022 - 01/2002
60	Chronic Obstructive Pulmonary Disease (COPD) 04/2022 - 06/2004
21	Allergic Rhinitis 01/2020 - 01/2005
14	Rhinitis 01/2020 - 02/2006
12	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017 - 02/2007
9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2007
8	Infections 01/2022 - 11/2005
7	Brain Diseases (Brain Disorder) 01/2022 - 01/2013
7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 05/2015
6	Inflammation (Inflammations) 01/2022 - 09/2008
6	Obstructive Lung Diseases (Obstructive Lung Disease) 11/2019 - 06/2004
5	Osteoporosis 01/2022 - 06/2009
5	Neoplasm Metastasis (Metastasis) 01/2016 - 11/2004
5	Seasonal Allergic Rhinitis (Hay Fever) 04/2015 - 05/2012
4	Confusion (Bewilderment) 01/2021 - 12/2009
4	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 11/2004
3	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2021 - 07/2014
3	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 05/2015
3	Hypoxia (Hypoxemia) 01/2020 - 01/2013
3	Obesity 11/2018 - 10/2011
3	Cataract (Cataracts) 11/2018 - 03/2013
3	Neoplasms (Cancer) 10/2015 - 08/2002
3	Facial Pain (Myofacial Pain) 01/2012 - 06/2008
3	Pheochromocytoma 09/2009 - 07/2003
2	Heart Diseases (Heart Disease) 04/2022 - 01/2009
2	Human Influenza (Influenza) 01/2022 - 05/2009
2	Glaucoma 02/2020 - 11/2018
2	Ischemia 01/2020 - 01/2019
2	Asphyxia (Suffocation) 01/2020 - 01/2013
2	Brain Injuries (Brain Injury) 10/2019 - 01/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2019 - 11/2018
2	Hypothermia 01/2019 - 01/2013
2	Hypersensitivity (Allergy) 12/2018 - 09/2016
2	Dyspnea (Shortness of Breath) 12/2017 - 01/2013

Drug/Important Bio-Agent (IBA)

79	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 09/2003
26	Bronchodilator Agents (Bronchodilators)IBA 04/2022 - 12/2005
24	Fluticasone (Cutivate)FDA LinkGeneric 01/2020 - 05/2007
17	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 06/2008
15	SteroidsIBA 01/2022 - 09/2003
15	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2015
14	GoldIBA 09/2019 - 06/2004
12	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2013
12	Muscarinic AntagonistsIBA 01/2022 - 12/2014
12	Pharmaceutical PreparationsIBA 12/2021 - 01/2005
9	azelastine (Optivar)FDA LinkGeneric 01/2020 - 05/2012
9	Formoterol Fumarate (Oxis)FDA Link 12/2019 - 10/2004
9	Beclomethasone (Beclometasone)FDA Link 01/2019 - 01/2002
9	Tiotropium Bromide (Spiriva)FDA Link 12/2015 - 08/2006
8	Insulin (Novolin)FDA Link 01/2022 - 01/2016
6	indacaterolIBA 01/2017 - 11/2011
6	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2017 - 07/2014
6	MP29-02IBA 01/2016 - 05/2012
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 11/2013
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 07/2007
5	AllergensIBA 01/2020 - 02/2006
5	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 09/2017 - 05/2007
5	Salmeterol Xinafoate (Serevent)FDA Link 01/2017 - 05/2007
5	Cholinergic Antagonists (Anticholinergics)IBA 04/2015 - 08/2006
5	montelukast (Singulair)FDA Link 10/2014 - 01/2005
4	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2022 - 01/2009
4	DiamondIBA 01/2021 - 01/2017
4	SmokeIBA 01/2021 - 03/2014
4	MelatoninIBA 02/2020 - 01/2013
4	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2020 - 01/2010
4	Histamine Antagonists (Antihistamines)IBA 01/2020 - 06/2008
4	Fluorouracil (Carac)FDA LinkGeneric 01/2016 - 11/2004
3	insulin receptor-related receptor (IRR)IBA 01/2021 - 10/2014
3	Immunoglobulin E (IgE)IBA 01/2020 - 06/2008
3	Protons (Proton)IBA 07/2019 - 01/2013
3	Theophylline (Theon)FDA LinkGeneric 01/2019 - 06/2015
3	GSK573719IBA 01/2017 - 07/2014
3	Yttrium-90IBA 01/2016 - 03/2007
3	Leucovorin (Folinic Acid)FDA Link 01/2016 - 11/2004
3	Albuterol (Salbutamol)FDA LinkGeneric 01/2014 - 06/2008
3	apaflurane (hydrofluoroalkane)IBA 07/2013 - 01/2002
2	Caspase 3 (Caspase-3)IBA 01/2022 - 01/2013
2	Biological ProductsIBA 01/2022 - 11/2019
2	Progestins (Progestagens)IBA 01/2021 - 01/2020
2	Estrogens (Estrogen)FDA Link 01/2021 - 01/2021
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 01/2018
2	Excipients (Suspending Agents)IBA 01/2020 - 01/2017
2	Lactic Acid (Lactate)FDA LinkGeneric 07/2019 - 01/2013
2	N-acetylaspartate (N-acetyl aspartate)IBA 07/2019 - 01/2013
2	Neuroprotective AgentsIBA 01/2019 - 01/2013
2	GlucocorticoidsIBA 01/2018 - 05/2011
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2018 - 01/2016
2	fluticasone-formoterolIBA 09/2017 - 02/2015
2	Hypoglycemic Agents (Hypoglycemics)IBA 08/2017 - 08/2015

Therapy/Procedure

93	Therapeutics 01/2022 - 10/2002
42	Nebulizers and Vaporizers (Inhaler) 01/2022 - 10/2004
11	Drug Therapy (Chemotherapy) 01/2021 - 11/2004
9	Dry Powder Inhalers 01/2022 - 04/2008
9	Injections 01/2021 - 05/2015
6	Induced Hypothermia 01/2022 - 01/2013
6	Metered Dose Inhalers (Metered Dose Inhaler) 01/2017 - 01/2010
5	Glycemic Control 01/2022 - 01/2003
3	Microspheres (Microsphere) 01/2016 - 03/2007
3	Complementary Therapies (Alternative Medicine) 05/2006 - 09/2003
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2021 - 01/2021
2	Biological Therapy 11/2019 - 01/2017